Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03891602 · ClinicalTrials.gov registry record
DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement
A clinical trial, sponsored by Hackensack Meridian Health.
- Completed
- Registry status
- 654
- Enrollment target
NCT03891602 is a clinical trial that has completed, run by Hackensack Meridian Health. The registered enrollment target is 654 participants.
The verdict
NCT03891602 has completed, sponsored by Hackensack Meridian Health.
- COMPLETED
- Registry status
- 654 participants
- Enrollment target
Study Summary
The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.
Interventions
- BEHAVIORAL Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale)
- BEHAVIORAL Patient Trust in the Medical
- BEHAVIORAL Decision Conflict Scale (DCS) - Lung Cancer Screening
- BEHAVIORAL Shared Decision Making Questionnaire (SDM-Q)- Patient
- BEHAVIORAL Stage of Readiness for Smoking Cessation - Contemplation Ladder
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 654 participants |
| Start Date | 2019-03-22 |
| Est. Completion | 2023-01-10 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03891602
The ClinicalTrials.gov registry entry for NCT03891602 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 654 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hackensack Meridian Health, which has 90 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale) is the first listed.
NCT03891602 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03891602 about?
NCT03891602 is a clinical study titled "DECIDE: Developing Tools for Lung Cancer Screening Discussion Improvement". The purpose of this study is to learn about discussion between clinicians and their patients related to lung screening. Survey answers will be collected from both clinicians and their patients.
What is the current status of trial NCT03891602?
This trial is currently completed. The enrollment target is 654 participants. The study started on 2019-03-22. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT03891602?
The interventions under investigation include: Cataldo Lung Cancer Stigma Scale (Smoking-Related Subscale) (BEHAVIORAL), Patient Trust in the Medical (BEHAVIORAL), Decision Conflict Scale (DCS) - Lung Cancer Screening (BEHAVIORAL), Shared Decision Making Questionnaire (SDM-Q)- Patient (BEHAVIORAL), Stage of Readiness for Smoking Cessation - Contemplation Ladder (BEHAVIORAL).
Who is sponsoring clinical trial NCT03891602?
This trial is sponsored by Hackensack Meridian Health, which has 90 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.